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Identity 




Human RPL26 cDNA was derived from mRNA 
isolated from human non-small cell lung cancer cell 
line SW-1573. 
Description 
RPL26 gene is 5731 bp in length consisting of 4 exons 
(the first is non-coding) and 3 introns located on the
minus strand of chromosome 17p. Exon 2 contains the 
translation initiator ATG and exon 4 contains the stop 
codon. The promoter of the RPL26 gene contains an 
oligopyrimidine tract, TATA-like sequence and a 
possible binding site for Ets protein family members. 
Transcription starts at a C-residue within the 
oligopyrimidine tract. 
Transcription 
RPL26 mRNA transcript is 602 bp in length. 
It has been reported that ribosomal protein L26 mRNA 
is preferentially expressed in normal early placenta 
(NEP) compared to L26 mRNA levels in gestational 
trophoblastic diseases (GTDs). 
Pseudogene 
36 human pseudogenes (Entrez Gene).  
An RPL26 processed pseudogene has been found 
within the intron of a functional RPS2 gene. 
Protein 
Description 
Eukaryotic ribosomes consist of a small 40S and large 
60S subunit. These ribosomal subunits are composed f 
4 ribosomal RNAs and over 80 ribosomal proteins. 
RPL26 is a ribosomal protein associated with the large 
60S subunit of the ribosome and contains a KOW 





RPL26 gene. Exons are represented by boxes (red corresponds to the 5' and 3'UTR; blue corresponds to the protein encoding 
sequence). The size of each exon is shown above the exon and the position of the exon within the gene is shown below each exon. 
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RPL26 protein is primarily localized in the cytoplasm, 
to a lesser extent, it is found in the nucleoplasm and
nucleolus. 
Function 
Ribosome biogenesis/stability: ribosome biogenesis is 
associated with proliferation, cell growth and stres 
responses. Eukaryotic ribosomes consist of a 40S and 
60S subunit that are composed of 4 ribosomal RNAs 
(rRNAs) and approximately 80 ribosomal proteins, 
ribosomal protein L26 is associated with the 60S 
subunit of the ribosome. The ratio of rRNAs to 
ribosomal proteins is tightly regulated within the c ll. 
An excess or reduction in either component can disrupt 
ribosome assembly. In a recent study investigating the 
role of ribosomal proteins in mammalian biogenesis, 
several ribosomal proteins, including RPL26, were 
individually depleted in HeLa cells using siRNAs. 
RPL26 knockdown resulted in a decrease in the amount 
of 60S ribosomal subunit as well as fully assembled 
ribosomes and polysomes. Also, knockdown of RPL26 
resulted in a significant decrease in synthesis of 28S 
rRNA (associated with 60S subunit) and interestingly 
18S rRNA (associated with 40S subunit). This work 
underscores the importance of RPL26, amongst other 
ribosomal proteins, in ribosome biogenesis. 
Translational regulation of mRNA: protein stability 
has largely been attributed to increases in p53 protein 
levels following DNA damage however, more recent 
reports show an increase in translation of p53 mRNA 
also contributes to p53 protein levels and is necessary 
for optimal induction of p53 following irradiation. In 
particular, the RPL26 protein binds to the 5'UTR of 
p53 mRNA following irradiation enhancing the 
association of p53 mRNA with polysomes thereby 
increasing translation of p53 mRNA. Furthermore, 
RPL26-mediated enhancement of p53 translation not 
only resulted in an increase in p53 protein levels but 
also in the transactivation of downstream p53 targets as 
demonstrated by the induction of G1 cell-cycle arrest 
and enhanced apoptosis. 
More recently, it has been shown that RPL26 binding 
to p53 mRNA following DNA damage requires not 
only the 5'UTR of p53 mRNA but also the 3'UTR. The 
interaction between complimentary sequences found  
within the 5' and 3'UTR of p53 mRNA creates a 
double-stranded RNA structure necessary for RPL26 
binding to p53 mRNA. Disruption of this double-
stranded RNA structure, either by base mutations in the 
two complementary UTR sequences or with a single-
stranded oligonucleotide targeting the 5'-3'UTR base 
pairing, abolishes binding of RPL26 to the p53 mRNA, 
RPL26-enhancement of p53 translation and p53-
mediated apoptosis. 
Ribosomal proteins are an integral component of 
protein synthesis however, evidence is emerging that 
ribosomal proteins have additional functions outside of 
protein synthesis. Translational regulation of RPL26 
mRNA has been shown to be an important feature of 
LPS-activation of human dendritic cells (DCs). During 
the early phase of DC maturation via LPS-activation, 
RPL26 mRNA is translated while during late phase of 
DC maturation, RPL26 mRNA is translationally down-
regulated as demonstrated by a reduction in polysomal-
bound RPL26 mRNA and overall RPL26 protein 
levels. Transcription of the RPL26 gene remained 
unchanged in all phases of LPS-activated DC 
maturation. 
Interaction with MDM2: regulation of p53 protein 
levels within the cell has largely been attributed to 
changes in p53 half-life. In the absence of DNA 
damage, p53 protein levels are kept low via p53 
interaction with MDM2, an E3-ubiquitin ligase that 
targets p53 for proteasomal degradation. After DNA 
damage, MDM2-mediated proteasomal degradation of 
p53 is abrogated allowing p53 protein levels to rapidly 
accumulate. Recently is has been reported that MDM2 
can also regulate p53 protein levels by targeting 
RPL26-mediated translation of p53 mRNA. In the 
absence of DNA damage, MDM2 binds to and 
polyubiquitinates RPL26 targeting the RPL26 protein 
for proteasomal degradation thereby attenuating 
RPL26-enhancement of p53 translation. Following 
DNA damage by irradiation, the inhibitory effect of
MDM2 on RPL26-enhancement of p53 translation is 
abrogated resulting in RPL26-mediated translation of 
p53 mRNA and accumulation of p53 protein.  
In addition to translational regulation of p53 mRNA, it 
has also been reported that overexpressed RPL26 can 
regulate p53 protein stability through interaction with 
MDM2. The interaction of RPL26 with MDM2 
stabilizes total p53 protein levels by blocking MDM2-
mediated ubiquitination of p53 protein and its 
subsequent proteasomal degradation. 
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Homology 
RPL26, a member of the L24P family of ribosomal 
proteins, is an evolutionary conserved protein found in 
all eukaryotes including M. musculus, R. norvegicus, 
D. melanogaster, C. elegans, S. pombe, S. cerevisia.  




No human RPL26 mutations have been reported. A cell 
line derived from a UV-induced murine tumor with 
both alleles of the RPL26 gene harboring different 
point mutations (P22S and H96Y) has been reported. 
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